Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SL-Tokyo: Effects of sitagliptin on lipid and glucose metabolism
jRCT1091220036Completed
- Sponsor
- Tokyo Medical and Dental University
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Tokyo Medical and Dental University. Primary endpoint: lipoprotein profile (lipoprotein subfractions). Started Mar 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1091220036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220036.